ELISA-like Assay for Hyaluronic Acid

Published: 7-Aug-2017
Analysis

AMSBIO have launched the Hyaluronic Acid Quantification Kit, based on a highly specific and tightly binding protein to detect and measure hyaluronic acid, also known as hyaluronan or HA

This product is a competitive ELISA-like kit using a recombinant hyaluronic acid binding protein (rHABP) optimised to quantify hyaluronic acid (HA) polymers of average molecular weight, greater than 7.4 kDa, in samples such as serum, plasma and culture supernatant.

HA is a glycosaminoglycan (GAG) with a simple structure widely found in extracellular matrix, synovial fluid, skin, umbilical cord and vitreous bodies; contributing to tissue water retention, cellular growth, cellular differentiation, and cellular migration.

HA is not immunogenic because of its simplicity and ubiquity, so classical immunological analysis has not been possible.

Recombinant HABP specifically detects HA, binding to HA from all species and tissues. It does not cross-react with other GAG's or to DNA. Recombinant production means that rHABP offers intrinsically higher safety compared with animal derived HABP.

Founded in 1987, AMS Biotechnology (AMSBIO) contributes to the acceleration of discovery through the provision of cutting edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries.

  • Companies:
  • AMS Biotechnology AMSBIO
See more

You may also like

Analysis

Tailored cryopreservation storage solutions for cell therapy manufacturing

Read more
CELLBANKER freezing media from AMSBIO is now available in customisable formats, seamlessly integrating into cell manufacturing processes with personalised formulations, volumes and packaging

Trending Articles

  1. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  2. Concept and Accelero Biostructures accelerate early drug discovery with X-ray crystallography The companies will incorporate their X-ray crystallography and drug discovery technologies to offer clients rapid hit-to-lead drug development
  3. Medac and chiron develop organ-on chip tech for animal free drug testing The companies aim to develop an animal-free pharmaceutical testing method that utilises organ-on chip technology, and will be used in rheumatoid arthritis drug testing
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Meeting new USP Chapter 41 requirements Balances are the essential means by which all therapeutics are ultimately supplied in safe dosages. Dirk Ahlbrecht, Sartorius Group, looks at how to ensure measurements are both accurate and up to new USP standards
  5. How iPSCs can bridge the translational gap in neuroscience Affecting more than one in three people, neurological disorders have a vast impact on global health while exacting a tremendous cost, reports Dr Max Mirza, Vice President of Neuroscience Drug Discovery at Sygnature Discovery

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Analysis

Tailored cryopreservation storage solutions for cell therapy manufacturing

CELLBANKER freezing media from AMSBIO is now available in customisable formats, seamlessly integrating into cell manufacturing processes with personalised formulations, volumes and packaging
Analysis

High performance magnetic beads for immunoassays

AMSBIO has expanded its range of high-performance magnetic beads for use as detection labels in magnetic immunoassays or as a solid support phase in immunoassays
Analysis

Spatial biology multi-omics profiling tools

Leading life sciences products and services provider - AMSBIO announce the launch of a custom service providing access to a suite of powerful spatial biology multi-omics profiling tools
Analysis

Cost-effective customisable ELISA assay kits

AMSBIO has announced a new range of customisable ELISA assay kits designed to enable experienced researchers to achieve reliable and reproducible assay results.
Ingredients

Fatty acid oxidation kit

AMSBIO has introduced the MitoXpress Xtra Fatty Acid Oxidation (FAO) kit to facilitate the convenient measurement of FAO-driven respiration
Manufacturing

AMSBIO expands US operations

Opens North American headquarters in Cambridge, Massachusetts
Research & Development

Concept and Accelero Biostructures accelerate early drug discovery with X-ray crystallography

The companies will incorporate their X-ray crystallography and drug discovery technologies to offer clients rapid hit-to-lead drug development
Subscribe now